共 50 条
- [41] Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma-the PriCoTTF phase I/II trialNEURO-ONCOLOGY, 2022, 24Kebir, S.Lazaridis, L.Schmidt, T.Oster, C.Feldheim, J.Glas, M.Pierscianek, D.Proescholdt, M.Hau, P.Grosu, A.Krex, D.Scheffler, B.Kleinschnitz, C.Pottgen, C.Stuschke, M.
- [42] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)NEURO-ONCOLOGY, 2018, 20 : 20 - 20Saran, FrankJames, AllanMcBain, CatherineJefferies, SarahHarris, FionaCseh, AgnieszkaPemberton, KarineSchaible, JenniferBender, ShaunBrada, Michael
- [43] SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA UNDERGOING RADIOTHERAPY PLUS TEMOZOLOMIDE AND ENZASTAURIN: RESULTS FROM A PHASE I/II TRIALNEURO-ONCOLOGY, 2010, 12 : 104 - 104Butowski, NicholasParvataneni, RupaNicole, AngelinaLamborn, KathleenPolley, MeiClarke, JenniferChang, SusanPage, MargarettaPrados, MichaelLiepa, AstraShi, P.Thornton, Donald
- [44] Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trialJOURNAL OF CANCER, 2019, 10 (14): : 3214 - 3223Du, Xiao-JingLi, Xian-MingCai, Lin-BoSun, Jian-CongWang, Si-YangWang, Xi-ChengPang, Xiao-LinDeng, Mei-LingChen, Fang-FangWang, Zhi-QiangChen, Fu-RongZhang, Hong-HongWang, Hui-YunPiedra, PatriciaChen, Zhong-PingLin, JunWu, Shao-Xiong
- [45] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma MultiformeADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340Chinot, O. L.Rouge, T. de la MotteMoore, N.Zeaiter, A.Das, A.Phillips, H.Modrusan, Z.Cloughesy, T.
- [46] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiformeAdvances in Therapy, 2011, 28 : 334 - 340O. L. ChinotT. de La Motte RougeN. MooreA. ZeaiterA. DasH. PhillipsZ. ModrusanT. Cloughesy
- [47] Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4412 - 4417Herrlinger, UlrichRieger, JohannesKoch, DorotheeLoeser, SimonBlaschke, BrittaKortmann, Rolf-DieterSteinbach, Joachim P.Hundsberger, ThomasWick, WolfgangMeyermann, RichardTan, Ta-ChihSommer, ClemensBamberg, MichaelReifenberger, GuidoWeller, Michael
- [48] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMAINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90Drappatz, JanNorden, Andrew D.Wong, Eric T.Doherty, Lisa M.LaFrankie, Debra C.Ciampa, AbigailKesari, SantoshSceppa, ChristineGerard, MaryPhan, PhuongSchiff, DavidBatchelor, Tracy T.Ligon, Keith L.Young, GeoffreyMuzikansky, AlonaWeiss, Stephanie E.Wen, Patrick Y.
- [49] Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiformeANNALS OF ONCOLOGY, 2005, 16 (07) : 1177 - 1184Barrié, MCouprie, CDufour, HFigarella-Branger, DMuracciole, XHoang-Xuan, KBraguer, DMartin, PMPeragut, JCGrisoli, FChinot, O
- [50] PHASE II STUDY OF BEVACIZUMAB, TEMOZOLOMIDE, AND HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HFSRT) FOR NEWLY DIAGNOSED GLIOBLASTOMANEURO-ONCOLOGY, 2011, 13 : 59 - 60Omuro, AntonioBeal, KathrynCorrea, DeniseChan, TimothyDeAngelis, LisaGavrilovic, IgorNolan, CraigHormigo, AdiliaLassman, Andrew B.Kaley, ThomasMellinghoff, IngoGrommes, ChristianPanageas, KathrynReiner, AnnBarradas, RenataAbrey, LaurenGutin, Philip